Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011252 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Francois D Rouleau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, Québec, Canada. Hauptthemen laut MEDLINE: Tetrahydrofolate Dehydrogenase, Pneumocystis carinii, Folic Acid Antagonists, Drug Resistance, Fungal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Fonds de recherche du Québec – Nature et technologies, Genome Canada.
Abstract (Originalsprache)
Pneumocystis jirovecii is a fungal pathogen that causes pneumocystis pneumonia, a disease that mainly affects immunocompromised individuals. This fungus has historically been hard to study because of our inability to grow it in vitro . One of the main drug targets in P . jirovecii is its dihydrofolate reductase (PjDHFR). Here, by using functional complementation of the baker’s yeast ortholog, we show that PjDHFR can be inhibited by the antifolate methotrexate in a dose-dependent manner. Using deep mutational scanning of PjDHFR, we identify mutations conferring resistance to methotrexate. Thirty-one sites spanning the protein have at least one mutation that leads to resistance, for a total of 355 high-confidence resistance mutations. Most resistance-inducing mutations are found inside the active site, and many are structurally equivalent to mutations known to lead to resistance to different antifolates in other organisms. Some sites show specific resistance mutations, where only a single substitution confers resistance, whereas others are more permissive, as several substitutions at these sites confer resistance. Surprisingly, one of the permissive sites (F199) is without direct contact to either ligand or cofactor, suggesting that it acts through an allosteric mechanism. Modeling changes in binding energy between F199 mutants and drug shows that most mutations destabilize interactions between the protein and the drug. This evidence points towards a more important role of this position in resistance than previously estimated and highlights potential unknown allosteric mechanisms of resistance to antifolate in DHFRs. Our results offer unprecedented resources for the interpretation of mutation effects in the main drug target of an uncultivable fungal pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec, Québec, Canada.
- Département de Biochimie, de Microbiologie et de Bio-Informatique, Faculté des Sciences et de Génie, Université Laval, Québec, Québec, Canada.
- Regroupement Québécois de recherche sur la fonction, la structure et l'ingénierie des protéines (PROTEO), Université du Québec à Montréal, Montréal, Québec, Canada.
- Centre de recherche en données massives de l'Université Laval (CRDM_UL), Québec, Québec, Canada.
- Département de Biologie, Faculté des Sciences et de Génie, Université Laval, Québec, Québec, Canada.
ORCID-Profile: Francois D Rouleau, Alexandre K Dubé, Isabelle Gagnon-Arsenault, Soham Dibyachintan, Philippe C Després, Patrick Lagüe, Christian R Landry
Förderung
- Canadian Institutes of Health Research
- Fonds de recherche du Québec – Nature et technologies
- Genome Canada
- Canada Excellence Research Chairs, Government of Canada
- Fondes de recherche du Québec - Nature et technologies
- PROTEO
- EvoFunPath CREATE
- Vanier Canada Graduate Scholarship agency
Zitieren
APA
Rouleau, F. D., Dubé, A. K., Gagnon-Arsenault, I., Dibyachintan, S., Pageau, A., Després, P. C., Lagüe, P., & Landry, C. R. (2024). Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011252
Vancouver
Rouleau FD, Dubé AK, Gagnon-Arsenault I, Dibyachintan S, Pageau A, Després PC, et al. Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011252
BibTeX
@article{Rouleau2024,
author = {Rouleau, Francois D and Dubé, Alexandre K and Gagnon-Arsenault, Isabelle and Dibyachintan, Soham and Pageau, Alicia and Després, Philippe C and Lagüe, Patrick and Landry, Christian R},
title = {Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011252}
}
EUVIMED